Stay updated with breaking news from Motor Aging. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Simultaneous declines in gait speed and cognition, particularly memory, are tied to a higher risk for dementia than gait-only or cognitive-only declines, a large new study shows.
MedRhythms, in collaboration with Boston University, is launching a clinical trial of its pipeline asset MR-005 in Parkinson’s disease (PD). In addition, the company is expanding its pipeline into aging with the development of its Aging Scientific Advisory Board (SAB). This follows MedRhythms’ announcement of the advancement of its pipeline into PD and multiple sclerosis (MS) in 2020 with the initiation of clinical trials and the development of MS and PD SABs. MedRhythms, headquartered in Portland, Me, is a digital therapeutics company that builds direct stimulation solutions that use cl...
MedRhythms Launches Clinical Trial of Digital Therapeutic in Parkinson's Disease and Expands Pipeline to Aging News provided by Share this article Share this article PORTLAND, Maine, April 13, 2021 /PRNewswire/ -- MedRhythms, a digital therapeutics company building direct stimulation solutions that use clinical-grade sensors, software and music to help restore function lost to neurologic disease or injury, today announced the initiation of a multi-site clinical trial, in collaboration with Boston University and one of the world's leading hospitals, of its pipeline asset MR-005 in Parkinson's ...